# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1068578 | Binding | Inhibition of pleckstrin homology domain of AKT by surface plasmon resonance spectroscopy | 14 | ALA1152590 | single protein format | Scientific Literature | ||
2. | ALA3888335 | Binding | Cellular Assay: Inhibition of AKT was measured by Western blotting using specific antibodies against phospho-Ser473-AKT in MiaPaCa-2 cells.Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008). | 8 | ALA3886664 | cell-based format | BindingDB Database | ||
3. | ALA4482511 | Binding | Binding affinity to recombinant human GAB1 PH domain expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay | Homo sapiens | 22 | ALA4482310 | assay format | Patent Bioactivity Data | |
4. | ALA4482512 | Binding | Binding affinity to recombinant human IRS1 PH domain expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay | Homo sapiens | 22 | ALA4482310 | assay format | Patent Bioactivity Data | |
5. | ALA4482513 | Binding | Binding affinity to AKT1 (unknown origin) by surface plasmon resonance assay | Homo sapiens | 22 | ALA4482310 | single protein format | Patent Bioactivity Data | |
6. | ALA4482514 | Binding | Inhibition of HGF-stimulated GAB1 Y627 phosphorylation in human T47D cells at 20 uM pre-incubated for 4 hrs before stimulation with HGF for 20 mins | Homo sapiens | 22 | ALA4482310 | cell-based format | Patent Bioactivity Data | |
7. | ALA4482515 | Functional | Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 4 days by MTT assay | Homo sapiens | 22 | ALA4482310 | cell-based format | Patent Bioactivity Data | |
8. | ALA4482516 | Functional | Cytotoxicity in human T47D cells assessed as reduction in cell viability incubated for 4 days by MTT assay | Homo sapiens | 22 | ALA4482310 | cell-based format | Patent Bioactivity Data | |
9. | ALA4482518 | Binding | Inhibition of HGF-induced IRS1 phosphorylation in human T47D cells assessed as pSer312 IRS1/total-IRS1 ratio level at 20 uM pre-incubated for 4 hrs before stimulation with HGF for 20 mins (Rvb = 100 +/- 0.02%) | Homo sapiens | 21 | ALA4482310 | cell-based format | Patent Bioactivity Data |